Unknown

Dataset Information

0

Albumin-based drug delivery: harnessing nature to cure disease.


ABSTRACT: The effectiveness of a drug is dependent on accumulation at the site of action at therapeutic levels, however, challenges such as rapid renal clearance, degradation or non-specific accumulation requires drug delivery enabling technologies. Albumin is a natural transport protein with multiple ligand binding sites, cellular receptor engagement, and a long circulatory half-life due to interaction with the recycling neonatal Fc receptor. Exploitation of these properties promotes albumin as an attractive candidate for half-life extension and targeted intracellular delivery of drugs attached by covalent conjugation, genetic fusions, association or ligand-mediated association. This review will give an overview of albumin-based products with focus on the natural biological properties and molecular interactions that can be harnessed for the design of a next-generation drug delivery platform.

SUBMITTER: Larsen MT 

PROVIDER: S-EPMC4769556 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6968566 | biostudies-literature
| S-EPMC8546853 | biostudies-literature
| S-EPMC4683017 | biostudies-literature
| S-EPMC5459032 | biostudies-other
| S-EPMC6808555 | biostudies-literature
| S-EPMC3810404 | biostudies-literature
| S-EPMC3129787 | biostudies-literature
| S-EPMC3617480 | biostudies-literature
| S-EPMC7747060 | biostudies-literature
| S-EPMC9882978 | biostudies-literature